TransCode Therapeutics Inc. Skyrocketed
Thu, Oct 10, 2024 at 07:49 PM
TransCode Therapeutics Inc. (RNAZ:NASDAQ) shot up at $0.73, a gain of 34.8%. On Thu, Oct 10, 2024, RNAZ:NASDAQ touched a New 2-Week High of $0.73. The stock got featured on our News Catalysts scanner on Thu, Oct 10, 2024 at 10:03 AM in the 'BIOTECH' category. From Thu, Sep 26, 2024, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Fri, May 10, 2024 at $2.01 with a volume of 13M+.
About TransCode Therapeutics Inc. (RNAZ:NASDAQ)
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics.
Top 10 Gainers:
- Reneo Pharmaceuticals Inc. (RPHM:NASDAQ), 952.02%
- SRAX, Inc. (SRAX:NASDAQ), 90.48%
- BloomZ Inc. (BLMZ:NASDAQ), 87.36%
- MicroAlgo Inc. (MLGO:NASDAQ), 48.65%
- Surf Air Mobility Inc. (SRFM:NYSE), 40.34%
- XChange TEC.INC American Depositary Shares (XHG:NASDAQ), 39.39%
- CN Energy Group Inc. (CNEY:NASDAQ), 36.38%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 34.85%
- A2Z Smart Technologies Corp. (AZ:NASDAQ), 34.34%
- Galaxy Payroll Group Limited (GLXG:NASDAQ), 33.77%